AMR Action Fund | $1B USD generated
The AMR Action Fund totals approx. $1B USD and has been generated by 23 pharma companies in partnership with the WHO. This fund will focus on treatments for drug resistant infections, a major threat to global health and already responsible for 700,000 deaths per year.
"We are hugely encouraged by the new Action Fund and the bridge it is creating to achieve a long lasting solution to AMR . It is imperative to have life saving antibiotics available for generations to come" | Lloyd J.Payne | EVP Head of Anti-Infectives Operations | Evotec
Lloyd Payne PhD, Evotec' s EVP Head of Anti-Infectives Operations, discusses what this funding means for the future of AMR | https://lnkd.in/dM4EVX5 | info@evotec.com #researchneverstops #AMR #antimicrobialresistance
